A Randomized, Real-world Head-to-head Study of Dupilumab Versus Mepolizumab in Danish CRSwNP Patients

Conditions:   Chronic Rhinosinusitis With Nasal Polyps;   Asthma; Eosinophilic;   Eosinophilia Interventions:   Biological: dupilumab;   Biological: mepolizumab Sponsor:   Rigshospitalet, Denmark Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials